Product Information
IPR-803 is a potent anticancer drug that belongs to the class of kinase inhibitors. It has been shown to induce apoptosis in human and Chinese hamster cancer cells by inhibiting the activity of proteins involved in cell growth and division. IPR-803 is derived from ranitidine, a medicinal compound used to treat ulcers and acid reflux. It has been found to be effective against various types of tumors and has shown promising results in clinical trials. This drug is excreted through urine and has low toxicity levels, making it a promising candidate for future cancer treatments.
Chemical properties
Technical inquiry about: 3D-SKB24335 IPR-803
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
